BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37993292)

  • 1. Primary aldosteronism: Practical recommendations for treatment and follow-up.
    Araujo-Castro M; Pascual-Corrales E; Martín Rojas P; Parra Ramírez P
    Hipertens Riesgo Vasc; 2023; 40(4):215-221. PubMed ID: 37993292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
    Weiner ID
    Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of primary hyperaldosteronism.
    Araujo-Castro M
    Med Clin (Barc); 2020 Oct; 155(7):302-308. PubMed ID: 32586668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of primary aldosteronism.
    Vilela LAP; Almeida MQ
    Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary aldosteronism - treatment options.
    Young WF
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S102-8. PubMed ID: 12914736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
    Carey RM
    Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.
    Young WF
    Endocrinology; 2003 Jun; 144(6):2208-13. PubMed ID: 12746276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
    Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
    Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of drug-based and surgical treatments for primary aldosteronism.
    Steichen O; Lorthioir A; Zinzindohoue F; Plouin PF; Amar L
    Adv Chronic Kidney Dis; 2015 May; 22(3):196-203. PubMed ID: 25908468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
    Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
    J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.
    Novello M; Catena C; Nadalini E; Colussi GL; Baroselli S; Chiuch A; Lapenna R; Bazzocchi M; Sechi LA
    J Hypertens; 2007 Jul; 25(7):1443-50. PubMed ID: 17563567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to the surgical management of primary aldosteronism.
    Iacobone M; Citton M; Viel G; Rossi GP; Nitti D
    Gland Surg; 2015 Feb; 4(1):69-81. PubMed ID: 25713782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
    Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
    Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Medical Treatment of Primary Aldosteronism.
    Li YJ; Ji ZG; Wen J
    Chin Med Sci J; 2023 Mar; 38(1):49-56. PubMed ID: 36642703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral Adrenalectomy for Primary Aldosteronism Due to Bilateral Adrenal Disease Can Result in Resolution of Hypokalemia and Amelioration of Hypertension.
    Szabo Yamashita T; Shariq OA; Foster TR; Lyden ML; Dy BM; Young WF; Bancos I; McKenzie TJ
    World J Surg; 2023 Feb; 47(2):314-318. PubMed ID: 36207420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry.
    Parra Ramírez P; Martín Rojas-Marcos P; Paja Fano M; González-Boillos M; Pascual-Corrales E; García Cano AM; Ruiz-Sanchez JG; Vicente Delgado A; Gómez Hoyos E; Ferreira R; García Sanz I; Recasens Sala M; Barahona San Millan R; Picón César MJ; Díaz Guardiola P; Perdomo CM; Manjón-Miguélez L; Rebollo Román Á; Robles Lázaro C; Morales-Ruiz M; Calatayud M; Andree Furio Collao S; Meneses D; Sampedro-Nuñez MA; Mena Ribas E; Sanmartín Sánchez A; Gonzalvo Diaz C; Lamas C; Guerrero-Vázquez R; Del Castillo Tous M; Serrano Gotarredona J; Michalopoulou Alevras T; Tenés Rodrigo S; Roa Chamorro R; Jaen Aguila F; Moya Mateo EM; Hanzu FA; Araujo-Castro M
    High Blood Press Cardiovasc Prev; 2024 Jan; 31(1):43-53. PubMed ID: 38225508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
    Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
    Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.